Why this call
Growth Juggernaut Hits New Highs
Continued market focus on blockbuster drug growth.
Positive pipeline developments and strategic acquisitions.
Sustained institutional buying and strong price trend.
Weather forecast
Eli Lilly and Co (LLY)
Sunny
Buy
Score 73/100 · Confidence 75%
The outlook is bright — conditions favour stepping in.
Weighed fromlive price action
Under the hood
What the engine weighed
Six factors, scored 0–100 from live market and financial data — the same read Wall Street does, minus the jargon.
0Overall score
Valuation
0
The stock's high valuation reflects steep expectations for future growth.
Growth
0
Exceptional revenue growth is the key driver of the investment case.
Profitability
0
The company operates with elite profit margins.
Momentum
0
The stock price is in a powerful and sustained uptrend.
Fin. health
0
The company uses a significant amount of debt to finance its growth.
Sentiment
0
Recent news on drug approvals and acquisitions has been very positive.
The argument
Both sides of the sky
Every call has a case against it. Here's the honest version of both.
The bull case
- Explosive revenue growth of nearly 50% is exceptional for a company of its size.
- The company is highly profitable, with a net margin of 35%, turning a large portion of sales into profit.
- Positive news, including regulatory progress for new drugs, is creating strong momentum.
The bear case
- The stock's valuation is high, with a P/E ratio of 41.9, meaning high expectations are already priced in.
- The company carries a notable amount of debt, with a Debt-to-Equity ratio of 1.39.
- Any slowdown in growth could significantly impact the stock price, given its premium valuation.
Get the full picture
That took thirty seconds.
Now imagine every stock you own.
You just understood LLY without reading a single chart. The Tickerday app does this for your whole watchlist — the full thesis, price targets from next week to next year, bull and bear scenarios — and wakes you the moment the weather turns.
One plain answer for every stock — Buy, Hold, or Sell
The full picture in seconds — thesis, targets & scenarios
Sleep easy — we watch the market and wake you if it turns
Free to download · 7-day free Tickerday+ trial inside